Emerson Electric Co. (EMR) Stock Forecast
EMR analyst forecast
as of October 18, 2026- Analyst consensus
- Buy 4.10 / 5 from 30 analysts
- Price target
- $175.14 average of analyst targets
- Upside to target
- +8.5% from the latest close
- Next earnings
- November 4, 2026 EPS estimate $1.84
- 52-week range
- $123.30 – $164.38
EMR analyst ratings
30 analystsNumber of analysts at each rating.
EMR price target
The average of analyst 12-month price targets compared with the latest close and the 52-week range.
EMR earnings per share estimates
| Period | Average | Low | High | Year ago | Growth | Analysts |
|---|---|---|---|---|---|---|
| Next quarter (Dec '26) | $1.63 | $1.52 | $1.71 | $1.46 | +11.5% | 15 |
| Current fiscal year (FY2026) | $6.56 | $6.54 | $6.61 | $6.00 | +9.4% | 28 |
| Next fiscal year (FY2027) | $7.28 | $6.77 | $7.53 | $6.56 | +10.9% | 29 |
Consensus EPS estimates; growth compares the average estimate with the year-ago EPS.
EMR revenue estimates
| Period | Average | Low | High | Growth | Analysts |
|---|---|---|---|---|---|
| Next quarter (Dec '26) | $4.60B | $4.54B | $4.71B | +5.8% | 12 |
| Current fiscal year (FY2026) | $18.90B | $18.83B | $19.13B | +4.9% | 27 |
| Next fiscal year (FY2027) | $19.96B | $19.62B | $20.36B | +5.6% | 28 |
EMR EPS: reported and forecast
Fiscal years; "E" marks estimates, the line shows the range from the lowest to the highest estimate.
EMR revenue: reported and forecast
EMR EPS estimate revisions
| Period | 90 days ago | 60 days ago | 30 days ago | 7 days ago | Now | Change (90 d) | Revisions (30 d) |
|---|---|---|---|---|---|---|---|
| Next quarter (Dec '26) | $1.60 | $1.61 | $1.62 | $1.63 | $1.63 | +1.7% | 1 up · 0 down |
| Current fiscal year (FY2026) | $6.51 | $6.55 | $6.56 | $6.56 | $6.56 | +0.8% | 6 up · 1 down |
| Next fiscal year (FY2027) | $7.18 | $7.23 | $7.25 | $7.27 | $7.28 | +1.4% | 5 up · 2 down |
How the consensus EPS estimate changed over the last 90 days, and how many analysts raised or lowered it in the last 30 days.
EMR earnings surprises
Reported EPS vs the consensus estimate for the last 12 quarters; EMR beat in 11 of 12.
What analysts expect from EMR
30 analysts cover Emerson; their consensus rating is buy (4.10 on a 1–5 scale, where 5 is a strong buy). The average price target is $175.14, 8.5% above the latest close of $161.47. Analysts expect earnings of $6.56 per share for FY2026, +9.4% from a year earlier. For FY2027 the average estimate is $7.28 per share on revenue of $20.0 billion. Emerson beat the EPS estimate in 11 of the last 12 quarters.
Related: EMR income statement, EMR key metrics, EMR chart. See the EMR stock overview for the latest quote and news.
EMR forecast FAQ
What is Emerson's price target?
The average analyst price target for Emerson is $175.14, 8.5% above the latest close of $161.47.
Is Emerson a buy, hold or sell?
Of 30 analysts covering Emerson, 16 rate it a strong buy, 4 a buy, 8 a hold, 1 a sell and 1 a strong sell, a consensus of buy. Ratings are opinions, not a recommendation from Quotelinks.
What is Emerson's EPS forecast?
Analysts forecast $6.56 per share for FY2026 (range $6.54 to $6.61); for FY2027 the estimate is $7.28.
What is Emerson's revenue forecast?
The average revenue estimate for FY2026 is $18.9 billion, growth of 4.9%; for FY2027 it is $20.0 billion.
When does Emerson report earnings?
Emerson is expected to report results for the quarter ending September 30, 2026 on November 4, 2026 before the market opens; the EPS estimate is $1.84.
Does Emerson usually beat earnings estimates?
Emerson reported EPS at or above the analyst estimate in 11 of the last 12 quarters.